⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 1, 2003Clinical Nephrology

N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients - a pilot study

Hernán Trimarchi Martina Mongitore Pablo Baglioni Matthew D. Forrester Emilio Freixas M. Schropp Horacio Pereyra Mirta Alonso

View at Publisher

Ask AI

Bookmark

Share

Abstract

MDA levels are elevated in chronic HD patients and are not significantly reduced by HD. NAC significantly reduces malondialdehyde levels in chronic HD patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Trimarchi et al. (2003) studied this question.

synapsesocial.com/papers/69d820f961e2ce1627d18d90 https://doi.org/10.5414/cnp59441

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Clinical course of rhabdomyolysis by etiology: Findings from a prospective cohort studyClinical Nephrology · 2026
2Association of IL-8 rs4073 −251T>A gene polymorphism with diabetic nephropathy in patients with type 2 diabetes mellitusClinical Nephrology · 2026
3Associations of base excess and alactic base excess with KDIGO stage 2 – 3 acute kidney injury in patients with acute ischemic strokeClinical Nephrology · 2026
4Comprehensive look at emergency admissions in renal care (CLEAR): A study from a tertiary care hospital in South IndiaClinical Nephrology · 2026
5Isolated primary glucosuria without SGLT2 mutation: A case reportClinical Nephrology · 2026

Analytical validation of an ELISA-based test kit for polymeric IgA immune complexes in IgA nephropathyClinical Nephrology · 2026
Fracture incidence and mortality in kidney transplant recipients compared with waitlisted dialysis patients: A single-center retrospective analysisClinical Nephrology · 2026
Associations of life’s crucial 9 and its components with all-cause and cardiovascular mortality in diabetic kidney disease patientsClinical Nephrology · 2026
Retrospective analysis of the effects of peritoneal dialysis modes, initial doses, and frequencies on residual renal function and quality of life in patients initiating peritoneal dialysisClinical Nephrology · 2026
Efficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from ChinaClinical Nephrology · 2026

More from Clinical Nephrology

More from Hospital Británico de Buenos Aires